Mannkind (MNKD) Assets (2010 - 2026)
Mannkind (MNKD) reported Assets of $744.4 million for Q1 2026, up 81.5% year-over-year from $410.1 million in Q1 2025, and down 6.03% quarter-over-quarter from $792.2 million in Q4 2025.
Mannkind (MNKD) Assets (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Assets data on file, last reported at $744.4 million in Q1 2026.
- Assets for Q1 2026 came in at $744.4 million, up 81.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $744.4 million (up 81.5% YoY), and the FY2025 annual result was $792.2 million, up 101.14% from the prior year.
- Assets eased to $744.4 million in Q1 2026 per MNKD's latest filing, from $792.2 million in the prior quarter.
- Over five years, Assets peaked at $792.2 million in Q4 2025 and troughed at $285.8 million in Q2 2022.
- A 5-year average of $425.1 million and a median of $410.1 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets retreated 17.12% in 2024, then soared 101.14% in 2025.
- A 5-year view of Assets shows it stood at $295.3 million in 2022, then surged by 60.93% to $475.2 million in 2023, then declined by 17.12% to $393.8 million in 2024, then soared by 101.14% to $792.2 million in 2025, then declined by 6.03% to $744.4 million in 2026.
- Business Quant data shows MNKD's Assets at $744.4 million in Q1 2026, $792.2 million in Q4 2025, and $494.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 744.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 744.40 Mn |
| Dec 31, 2025 | 792.18 Mn |
| Sep 30, 2025 | 494.64 Mn |
| Jun 30, 2025 | 411.70 Mn |
| Mar 31, 2025 | 410.14 Mn |
| Dec 31, 2024 | 393.84 Mn |
| Sep 30, 2024 | 464.20 Mn |
| Jun 30, 2024 | 443.84 Mn |
| Mar 31, 2024 | 480.88 Mn |
| Dec 31, 2023 | 475.20 Mn |
| Sep 30, 2023 | 320.33 Mn |
| Jun 30, 2023 | 313.42 Mn |
| Mar 31, 2023 | 298.14 Mn |
| Dec 31, 2022 | 295.28 Mn |
| Sep 30, 2022 | 293.84 Mn |
| Jun 30, 2022 | 285.80 Mn |
| Mar 31, 2022 | 308.32 Mn |
| Dec 31, 2021 | 321.16 Mn |
| Sep 30, 2021 | 238.21 Mn |
| Jun 30, 2021 | 252.79 Mn |